loadpatents
name:-0.041873931884766
name:-0.032510995864868
name:-0.034847974777222
ROMERO; F. Anthony Patent Filings

ROMERO; F. Anthony

Patent Applications and Registrations

Patent applications and USPTO patent grants for ROMERO; F. Anthony.The latest application filed is for "thyroid hormone receptor beta agonist compounds".

Company Profile
32.29.38
  • ROMERO; F. Anthony - Redwood City CA
  • Romero; F. Anthony - South San Francisco CA
  • Romero; F. Anthony - Brisbane CA
  • - South San Francisco CA US
  • Romero; F. Anthony - Westfield NJ US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Thyroid Hormone Receptor Beta Agonist Compounds
App 20220281849 - KIRSCHBERG; Thorsten A. ;   et al.
2022-09-08
Therapeutic Compounds And Uses Thereof
App 20220127265 - Cyr; Patrick ;   et al.
2022-04-28
Pyrazolopyrimidine Aryl Ether Inhibitors Of Jak Kinases And Uses Thereof
App 20220106322 - Zak; Mark Edward ;   et al.
2022-04-07
Compounds As Glp-1r Agonists
App 20220089578 - ROMERO; F. Anthony ;   et al.
2022-03-24
Therapeutic compounds and uses thereof
Grant 11,247,989 - Cyr , et al. February 15, 2
2022-02-15
Therapeutic Compounds And Compositions, And Methods Of Use Thereof
App 20220024945 - ZAK; Mark ;   et al.
2022-01-27
Thyroid hormone receptor beta agonist compounds
Grant 11,203,587 - Kirschberg , et al. December 21, 2
2021-12-21
Therapeutic compounds and uses thereof
Grant 11,168,070 - Cyr , et al. November 9, 2
2021-11-09
Pyrazolopyrimidine compounds and methods of use thereof
Grant 11,155,557 - Romero , et al. October 26, 2
2021-10-26
Pyrazolochlorophenyl Compounds, Compositions And Methods Of Use Thereof
App 20210179626 - ZAK; Mark ;   et al.
2021-06-17
Therapeutic Compounds, Compositions And Methods Of Use Thereof
App 20210179564 - Crawford; James John ;   et al.
2021-06-17
Tricyclic ASK1 inhibitors
Grant 10,919,911 - Xu , et al. February 16, 2
2021-02-16
Substituted benzoimidazoles and imidazo[4,5-c]pyridines for treating certain leukemias
Grant 10,889,571 - Romero , et al. January 12, 2
2021-01-12
Therapeutic Compounds And Uses Thereof
App 20200399244 - Cyr; Patrick ;   et al.
2020-12-24
Tetrazole-substituted Pyrazolopyrimidine Inhibitors Of Jak Kinases And Uses Thereof
App 20200399274 - Zak; Mark Edward ;   et al.
2020-12-24
Therapeutic Compounds And Compositions, And Methods Of Use Thereof
App 20200352951 - ZAK; Mark ;   et al.
2020-11-12
Thyroid hormone receptor beta agonist compounds
Grant 10,800,767 - Kirschberg , et al. October 13, 2
2020-10-13
8-(azetidin-1-yl)-[1,2,4]triazolo[1,5-a]pyridinyl Compounds, Compositions And Methods Of Use Thereof
App 20200270248 - GOODACRE; Simon Charles ;   et al.
2020-08-27
Therapeutic compounds and uses thereof
Grant 10,696,655 - Cyr , et al. June 30, 2
2020-06-30
Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
Grant 10,689,416 - Hudson , et al.
2020-06-23
Thyroid Hormone Receptor Beta Agonist Compounds
App 20200115362 - KIRSCHBERG; Thorsten A. ;   et al.
2020-04-16
Compounds For Treating Certain Leukemias
App 20200087283 - ROMERO; F. Anthony ;   et al.
2020-03-19
Thyroid Hormone Receptor Beta Agonist Compounds
App 20200062742 - KIRSCHBERG; Thorsten A. ;   et al.
2020-02-27
Therapeutic Compounds And Compositions, And Methods Of Use Thereof
App 20200062779 - ZAK; Mark ;   et al.
2020-02-27
Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
App 20200002378 - Hudson; Ryan ;   et al.
2020-01-02
Pyrazolochlorophenyl Compounds, Compositions And Methods Of Use Thereof
App 20200002346 - ZAK; Mark ;   et al.
2020-01-02
Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
Grant 10,519,197 - Hudson , et al. Dec
2019-12-31
Pyrazolopyrimidine Compounds And Methods Of Use Thereof
App 20190345165 - ROMERO; F. Anthony ;   et al.
2019-11-14
Tricyclic Ask1 Inhibitors
App 20190315767 - XU; Yingzi ;   et al.
2019-10-17
Therapeutic Compounds And Compositions, And Methods Of Use Thereof
App 20190240227 - ZAK; Mark ;   et al.
2019-08-08
Therapeutic Compounds And Uses Thereof
App 20190241558 - Cyr; Patrick ;   et al.
2019-08-08
Therapeutic compounds and uses thereof
Grant 10,358,437 - Albrecht , et al.
2019-07-23
8-(azetidin-1-yl)-[1,2,4]triazolo[1,5-a]pyridinyl Compounds, Compositions And Methods Of Use Thereof
App 20190202822 - GOODACRE; Simon Charles ;   et al.
2019-07-04
Therapeutic compounds and uses thereof
Grant 10316023 -
2019-06-11
Therapeutic compounds and compositions, and methods of use thereof
Grant 10,307,426 - Zak , et al.
2019-06-04
Therapeutic compounds and uses thereof
Grant 10,308,614 - Albrecht , et al.
2019-06-04
Therapeutic Compounds And Uses Thereof
App 20190152949 - Cyr; Patrick ;   et al.
2019-05-23
Therapeutic compounds and uses thereof
Grant 10,280,149 - Albrecht , et al.
2019-05-07
Therapeutic compounds and uses thereof
Grant 10,258,603 - Albrecht , et al.
2019-04-16
Therapeutic Compounds, Compositions And Methods Of Use Thereof
App 20190071404 - Crawford; James John ;   et al.
2019-03-07
Therapeutic compounds and uses thereof
Grant 10,206,931 - Romero , et al. Feb
2019-02-19
Therapeutic compounds and uses thereof
Grant 10,202,354 - Albrecht , et al. Feb
2019-02-12
Therapeutic compounds and uses thereof
Grant 10,202,378 - Adler , et al. Feb
2019-02-12
Therapeutic compounds and uses thereof
Grant 10,183,009 - Albrecht , et al. Ja
2019-01-22
Therapeutic Compounds And Compositions, And Methods Of Use Thereof
App 20180334465 - ZAK; Mark ;   et al.
2018-11-22
Therapeutic Compounds And Compositions, And Methods Of Use Thereof
App 20180333416 - ZAK; Mark ;   et al.
2018-11-22
Therapeutic Compounds And Uses Thereof
App 20180022707 - Albrecht; Brian K. ;   et al.
2018-01-25
Therapeutic Compounds And Uses Thereof
App 20180022727 - Albrecht; Brian K. ;   et al.
2018-01-25
Therapeutic Compounds And Uses Thereof
App 20170333406 - Adler; Marc ;   et al.
2017-11-23
Therapeutic compounds and uses thereof
Grant 9,763,922 - Adler , et al. September 19, 2
2017-09-19
Therapeutic Compounds And Uses Thereof
App 20160158207 - Adler; Marc ;   et al.
2016-06-09
Spiroxazolidinone compounds
Grant 8,742,110 - Duffy , et al. June 3, 2
2014-06-03
Cyclic benzimidazole derivatives useful as anti-diabetic agents
Grant 8,563,746 - Dang , et al. October 22, 2
2013-10-22
Spiroxazolidinone Compounds
App 20130131042 - Duffy; Joseph L. ;   et al.
2013-05-23
Cyclic benzimidazole derivatives useful as anti-diabetic agents
Grant 8,410,284 - Dang , et al. April 2, 2
2013-04-02
Cyclic benzimidazole derivatives useful as anti-diabetic agents
Grant 8,394,969 - Bookser , et al. March 12, 2
2013-03-12
Spiro Isoxazoline Compounds As Sstr5 Antagonists
App 20130040978 - Duffy; Joseph L. ;   et al.
2013-02-14
Cyclic benzimidazole derivatives useful as anti-diabetic agents
Grant 8,329,914 - Bao , et al. December 11, 2
2012-12-11
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents
App 20110263533 - Dang; Qun ;   et al.
2011-10-27
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents
App 20110218174 - Bao; Jianming ;   et al.
2011-09-08
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents
App 20110195964 - Dang; Qun ;   et al.
2011-08-11
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents
App 20100081643 - BOOKSER; BRETT C. ;   et al.
2010-04-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed